MIT Technology Review

Gene therapy is saving children’s lives—but screening to discover who needs it is lagging behind | May 31, 2018

States have been slow to adopt newborn tests for genetic conditions.

Before he died, this biohacker was planning a CRISPR trial in Mexico |  May 4, 2018
Aaron Traywick and his company, Ascendance Biomedical, are connected to a website advertising a gene-therapy trial for lung cancer.

CRISPR trials are about to begin in people—but we still don’t know how well it works in monkeys | April 11, 2018

Monkey studies look encouraging but show there’s still a lot to learn about the technology.

AI can spot signs of Alzheimer’s before your family does | March 19, 2018
Earlier diagnosis could help researchers develop drugs to slow the progress of the disease.

Fast genome tests are diagnosing some of the sickest babies in time to save them | March 8, 2018

Rapid DNA sequencing is helping doctors treat critically ill infants in days rather than weeks.


Gene-altering treatments are medicine’s best shot yet against Huntington’s disease | Feb. 15, 2018

After 25 years, scientists are starting to make progress against the devastating illness.

Men will soon test a sperm-stopping gel for birth control | Dec. 20, 2017

The gel might deliver hormones better than injections or pills.

CRISPR in 2018: Coming to a human near you | Dec. 18, 2017

The first clinical trials using the gene-editing technology are slated to begin in the U.S. and Europe.

Biohackers disregard FDA warning on DIY gene therapy | Dec. 1, 2017

The regulatory agency is cracking down on companies offering kits to produce gene therapies for self-administration.

FDA vote sets stage for gene therapy’s future | Oct. 12, 2017
The first therapy that fixes an inherited genetic trait could soon be available in the U.S.

Sickle cell patients see hope in CRISPR | Aug. 23, 2017

Long underserved by the medical establishment and Big Pharma, sickle cell disease is now being eyed for the first human tests of the gene-editing tool.

The fertility doctor trying to commercialize three-parent babies | June 13, 2017

A startup called Darwin Life says it will use a controversial fertility technique to help forty-somethings get pregnant for $100,000.

A year after approval, a gene-therapy cure gets its first customer | May 3, 2017 

GlaxoSmithKline has so far treated only one child with Strimvelis, its gene therapy for immune deficiency.

When even genome sequencing doesn’t give a diagnosis | April 21, 2017

The technology has been touted as a powerful diagnostic tool, but it doesn’t provide answers to everyone.

This gadget has a real working menstrual cycle | March 28, 2017
The latest organ-on-a-chip can release an egg in 28 days. 

Determined parents are moving the needle on gene therapy | March 21, 2017

Families of patients are starting advocacy groups, raising money for research, and founding biotech companies to advance cures for rare diseases.

Do your family members have a right to your genetic code? | Nov. 22, 2016
When a woman gets her genome sequenced, questions about privacy arise for her identical twin sister.

17 and going blind: the high stakes of getting into a gene therapy trial | Sept. 19, 2016
For patients with some inherited diseases, a chance to test an experimental treatment can offer the only hope.


© 2019 Emily Mullin

  • Grey Twitter Icon
  • Grey LinkedIn Icon